Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells

The development of a substance or inhibitor-based treatment strategy for the prevention of aortic valve stenosis is a challenge and a main focus of medical research in this area. One strategy may be to use the tankyrase inhibitor XAV-939, which leads to Axin stabilisation and subsequent destruction...

Descripción completa

Detalles Bibliográficos
Autores principales: Dittfeld, Claudia, Reimann, Gabriel, Mieting, Alice, Büttner, Petra, Jannasch, Anett, Plötze, Katrin, Steiner, Gerald, Tugtekin, Sems Malte, Matschke, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286025/
https://www.ncbi.nlm.nih.gov/pubmed/30532256
http://dx.doi.org/10.1371/journal.pone.0208774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286025/
https://www.ncbi.nlm.nih.gov/pubmed/30532256
http://dx.doi.org/10.1371/journal.pone.0208774

Ejemplares similares